Purchase Order 75N92B18P00014
Award Date 5/30/18
Potential Completion Date 5/30/18
Potential Value $25K
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Pleasanton, CA 94566, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
3
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- <p>The National Institute of Arthritis and Musculoskeletal and Skin Diseases awarded a purchase order to 10X Genomics, Inc. valued at $20,509.00 on July 9, 2018, with completion on July 8, 2019. Performance took place in Pleasanton, California. The order was issued on a firm fixed price basis with no small business set-aside. The source does not specify the items or services procured.</p>
- <p>The National Institute of Arthritis and Musculoskeletal and Skin Diseases awarded a purchase order to 10X Genomics, Inc. on August 20, 2018, with a ceiling value of $23,245.00 and a firm fixed price. No set-aside was used. Performance is located in Pleasanton, California. The order was ultimately completed on August 19, 2019.</p>
- <p>The National Institute of Arthritis and Musculoskeletal and Skin Diseases awarded a purchase order to 10X Genomics, Inc. for $23,534.00 on August 7, 2018. Performance is located in Pleasanton, California. The order period runs from August 7, 2018 through August 6, 2019. 10X Genomics supplies single-cell and spatial transcriptomics platforms, reagents, and consumables to federal research agencies.</p>
- <p>The National Institute of Arthritis and Musculoskeletal and Skin Diseases awarded a purchase order to 10X Genomics, Inc. for $21,600 on December 19, 2019. The order, which carries no set-aside designation, covers a platform supporting cell transcriptomics and cell-type identification and discovery. Work is performed at the vendor's facility in Pleasanton, California. The order is firm-fixed-price and concludes on December 26, 2019.</p>
- <p>The National Institute of Arthritis and Musculoskeletal and Skin Diseases awarded a purchase order to 10X Genomics, Inc. valued at $24,896.00 on May 7, 2019, with an ultimate completion date of May 31, 2019. No set-aside was used. Place of performance is Bethesda, Maryland. The order is priced on a firm fixed price basis. Specific requirements are not detailed in the source.</p>
- <p>The National Institute of Arthritis and Musculoskeletal and Skin Diseases awarded a purchase order to 10X Genomics, Inc. valued at $22,887.00 on July 5, 2018. Place of performance is Pleasanton, California. The order covers genomic analysis instruments, consumables, or bioinformatics software supplied by the vendor. No set-aside applied. Ultimate completion date is July 5, 2018.</p>
- <p>The National Institute of Arthritis and Musculoskeletal and Skin Diseases awarded a purchase order to 10X Genomics, Inc. valued at $22,887.00 on August 2, 2018, with completion by August 30, 2018. Work is performed in Pleasanton, California. The order is for commercial genomic analysis instruments, consumables, or reagents supplied on a firm fixed price basis. No set-aside applies.</p>
- <p>The National Institute of Arthritis and Musculoskeletal and Skin Diseases awarded a purchase order to 10X Genomics, Inc. valued at $24,119.00 on March 5, 2020, with completion by March 12, 2020. No set-aside was used. Performance occurred in Pleasanton, California. The order was issued on a firm fixed price basis for genomic analysis products and related supplies.</p>
- <p>The National Institute of Arthritis and Musculoskeletal and Skin Diseases awarded a purchase order to 10X Genomics, Inc. for $22,310.60 on February 19, 2019, with completion on February 18, 2020. No set-aside was used. Performance occurs in Pleasanton, California. The order is priced on a firm fixed price basis for commercial genomic analysis instruments, consumables, or bioinformatics software supporting the institute's research operations.</p>
- The National Institute of Arthritis and Musculoskeletal and Skin Diseases awarded a purchase order to 10X Genomics, Inc. for $23,084.00 on December 12, 2017. The order covers custom single-cell RNA-sequencing services using 10X Genomics technology. Place of performance is Pleasanton, California. The period of performance runs from December 12, 2017 through December 11, 2018, with an ultimate completion date of January 31, 2018. The contract is firm fixed price with no set-aside category...
The National Institute of Arthritis and Musculoskeletal and Skin Diseases awarded a purchase order to 10X Genomics, Inc. for $24,895 on May 30, 2018, with no small business set-aside. The order covers somatic mutation research on autoimmune patient samples and performs at the awardee's Pleasanton, California facility. Ultimate completion is May 30, 2018. Pricing is firm fixed price.
Generated 8/1/26, 10:34 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $24.9k | 5/29/18 |